Author

Anamitra Ghosh

Baylor College of MedicineORCID 0000-0001-9740-2070Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Hui ZhengiD· 2 shared Michele M. Comerota· 2 shared Ah-Young JangiD· 1 shared Anumantha G. KanthasamyiD· 1 shared Arthi KanthasamyiD· 1 shared Arunkumar AsaithambiiD· 1 shared Baijayanti Ghosh· 1 shared Bruce D. HammockiD· 1 shared

Activity by Year

2020-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Hui ZhengORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NeurosciencebioRxivPreprintOct 20, 2026

Astrocytic sEH-EET signaling regulates microglial lysosomal function and suppresses the STING-Type I interferon pathway in Alzheimer's disease

Baijayanti Ghosh, Shuo Wang, Chuangye Qi…·Hui Zheng

This study identifies an astrocyte-microglia signaling axis in Alzheimer's disease where astrocytic sEH limits EET availability, promoting lysosomal clearance of pSTING and suppressing type I IFN signaling.

DOI 10.64898/2026.10.16.759679

mousescRNA-seq

𝕏 PostBluesky

NeurosciencebioRxivPreprintFeb 13, 2025

Rationally Designed PKD1 Activator Protects Against Neurodegeneration in Pre-clinical Models of Parkinson's Disease

Arunkumar Asaithambi, Ah-Young Jang, Anamitra Ghosh…·Anumantha G. Kanthasamy

The paper develops a rationally designed PKD1 activator peptide, AK-P4T, which protects against neurodegeneration in pre-clinical Parkinson's disease models.

DOI 10.1101/2025.02.13.637661

mouseexperimental assay

𝕏 PostBluesky

NeurosciencebioRxivPreprintJun 30, 2020

Epoxy fatty acid dysregulation and neuroinflammation in Alzheimer's disease is resolved by a soluble epoxide hydrolase inhibitor

Anamitra Ghosh, Michele M. Comerota, Debin Wan…·Hui Zheng

The paper shows that soluble epoxide hydrolase is upregulated in AD and that its inhibition restores brain epoxy fatty acids, ameliorates neuropathology, and improves cognitive function.

6 citations

mousehuman

𝕏 PostBluesky